
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1031 | 1020 | 1107 | 1238 | 1638 | 1930 |
Fund Return | 3.12% | 1.97% | 10.73% | 7.37% | 10.37% | 6.8% |
Place in category | 1684 | 3740 | 4933 | 2093 | 1414 | 1090 |
% in Category | 26 | 55 | 76 | 39 | 34 | 47 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS CH Institutional Fund 2 EquiP2X | 8.13B | 0.98 | 11.71 | 12.36 | ||
UBS CH Institutional Fund 2 EquiPAX | 4.28B | 2.19 | 10.23 | 9.88 | ||
UBS CH Vitainvest 50 World U | 4.27B | 7.32 | -1.50 | 2.35 | ||
UBS CH Institutional Fund 2 EquiSCX | 2.9B | 3.63 | 3.95 | 8.17 | ||
UBS CH Institutional Fund 2 EquiSCB | 2.9B | 3.63 | 3.89 | 8.11 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0429081620 | 7.3B | 28.87 | 6.79 | - | ||
Swisscanto CH IPF I Index Equity Fu | 7.28B | 3.52 | 9.32 | 10.99 | ||
CH0337393745 | 6.05B | 27.07 | 6.15 | - | ||
Swisscanto CH IPF III Index EquAST | 5.79B | 28.59 | 6.60 | 9.22 | ||
UBS CH Institutional Fund 2 EquiPAX | 4.28B | 2.19 | 10.23 | 9.88 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 5.37 | 387.82 | +1.12% | |
Amazon.com | US0231351067 | 3.84 | 195.54 | +1.41% | |
Broadcom | US11135F1012 | 3.34 | 195.57 | +3.66% | |
UnitedHealth | US91324P1021 | 2.48 | 503.20 | -0.12% | |
Eli Lilly | US5324571083 | 2.43 | 837.01 | +1.76% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review